Galsky, Matt D. Grande, Enrique Davis, Ian D. De Santis, Maria Arija, Jose Angel Arranz Kikuchi, Eiji Mecke, Almut and Thastrom, Ann Christine Bamias, Aristotelis, IMvigor130: A randomized, phase III study evaluating first-line (1L)
atezolizumab (atezo) as monotherapy and in combination with
platinum-based chemotherapy (chemo) in patients (pts) with locally
advanced or metastatic urothelial carcinoma (mUC)., World Journal of Clinical Oncology, (36), 2018, AMER SOC CLINICAL ONCOLOGY 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA,